Controlled release co-matrix tablets of Ciprofloxacin HCl were prepared with different types of bioadhesive polymers e.g. Methocel K4M, Methocel K 15M CR and Methocel K 100LV, Povidone K-30, and Xanthan gum. Tablets prepared by direct compression method were subjected to in-vitro drug dissolution study for 8 hours in a simulated gastric fluid media using USP dissolution apparatus II with 50 rpm at 37±0.5ºC. The bio-adhesive property was investigated in terms of retention time following in-vitro wash-off method. The concentrations of polymers were varied to investigate whether these variations can cause any change in release of Ciprofloxacin HCl molecule and bio-adhesion property or not. In most of the cases it is found that Methocel K4M and Methocel K100LV based co-matrix tablets release greater percentage of active drug than Methocel K15M CR based co-matrix tablets. Bio-adhesive strength of Methocel K15M CR and Xanthan gum based co-matrix tablets was proved to be maximum followed by Methocel K4M and Xanthan gum based co-matrices. Whereas Methocel K100LV and Xanthan gum based co-matrices showed little or poor muco-adhesion. Methocel K4M, K15M CR and Xanthan gum based formulations showed nearly zero-order release, on the other hand Methocel K100LV and Xanthan gum based formulation showed a burst release within one hour of dissolution. Finally it was revealed that Xanthan gum provided optimum bio-adhesion functioning as a synergist in co-matrices and comply the USP specification as a most suitable controlled release polymer.
INTRODUCTION
Orally administered controlled release dosage form shows mainly two adversities; first too short gastric retention time (GRT) and secondly unpredictable gastric emptying time. A relatively brief gastro intestinal (GI) transit time of most of the products (8-12 hours) impedes the formulation of single daily dosage forms. These problems can be overcome by altering the gastric emptying time, which is affected by age, sex, and health condition of a subject. It is therefore desirable to formulate a sustained release dosage form that gives an extended GI residence time. Various approaches have been worked out to improve the retention time of an oral dosage form in the stomach including bio-adhesive (gastro retentive) systems. 1 Bio-adhesive systems are usually exploited to localize a delivery device within the cavity of body to improve the drug absorption process in site-specific manner 2 . The matrix system is commonly used for manufacturing sustained release dosage forms because; it makes such manufacturing easy. 3 Polymers belonging to hydrophilic matrix systems, when exposed to an aqueous medium does not disintegrate but immediately after hydration develops a highly viscous gelatinous surface barrier which controls the drug release from and the liquid penetration into the center of the matrix system, that increases the retention time on mucosal surfaces and may lead to adhesive interaction. 4 The present study is designed to study the capacity of hydrophilic polymers as release retarding ingredient and muco-adhesive agent over drug molecule in terms of dissolution study, gastro retention time and subsequent data analysis.
MATERIALS AND METHODS
Ciprofloxacin HCl monohydrate was procured from Beximco Pharmaceuticals Limited. Methocel K4M, Methocel K15M CR and Methocel K100LV were collected from Colorcon, USA . Povidone K-30, Sodium bicarbonate (NaHCO 3 ), Citric acid, Microcrystalline cellulose (Avicel PH 102) and Xanthan gum were collected from Loba Chem pvt. Ltd, India. Magnesium stearate and Aerosil were obtained from Hanau Chemicals Ltd. (Japan). For determining bio-adhesive strength, gastric mucosa of cow was obtained from a local slaughterhouse in Dhaka. All other reagents employed were of analytical or pharmaceutical grade.
Preparation of Co-matrix tablets by direct compression technique. The method includes blending of the active ingredients with polymers, filler, lubricant and flow promoter followed by direct compression. Table-1 represents the formulation of co-matrix tablets with their formulation code. Amount of active drug was constant (582 mg) in all cases. Total weight of tablets was 1000 mg. The required amount of active drug and polymers were weighted separately mixed thoroughly in a drum blender. Co-matrix tablets were prepared by Manesty 16 station rotary press applying a compression force of 3 ton. All the tablets were then stored in air tight containers at room temperature for further investigation.
In-vitro Dissolution study. In-vitro drug release studies of the prepared co-matrix tablets were carried out in a USP XXII dissolution apparatus II (paddle) equilibrated at 37 ± 0.5°C with 50 rpm. The dissolution study was performed for 8 hours in 900 mL of 0.1 N HCl (hydrochloric acid, pH 1.2) under sink condition. Sample solution was analyzed for Ciprofloxacin HCl at 276 nm 5 by an UV spectrophotometer (Shimadzu, Japan). The amount of drug present in the sample tablets was calculated with appropriate calibration curve constructed from reference standards. Drug dissolved at specified time period was plotted as percent release versus time (hours) curve.
Bio-adhesive testing by in-vitro wash-off test.
The bio-adhesive property of the prepared tablets was evaluated by an in-vitro adhesion testing method known as wash-off method. Freshly excised pieces of intestinal mucosa (4X3 inch) from cow were mounted on the stainless steel slide, connected with a suitable support. Three tablets were placed on to wet rinsed tissue specimen and immediately there after the support was hung to the arm of the USP tablet disintegrating test machine. When the disintegrating machine was operated, the tissue specimen was given a slow, regular up and down movement in the gastric fluid (pH 1.2) at 37°C contained in a one liter vessel of the machine. Similar experiments were also cited. 6 
Kinetic modeling of drug release.
After completing in vitro dissolution of all the batches for eight hours, the data were treated with zero order equation 7 and Higuchi equations 8 (equation 1-2 respectively).
In these equations, M t is the cumulative amount of drug released at any specified time (t) and M 0 is the dose of the drug incorporated in the delivery system. k 0 and k H are rate constants for zero order and Higuchi model respectively. These models failed to explain drug release mechanism due to swelling (upon hydration) along with gradual erosion of the matrix. Therefore the dissolution data were also fitted to well-known Korsmeyer kinetic equation 9 to ascertain the mechanism of drug release.
log (M t /M ∞ ) = logk + nlogt…………….(3)
Where M ∞ is the amount of drug release after infinite time; k is the release rate constant which considers structural and geometric characteristics of the tablet; and n is the diffusional exponent or release exponent; indicative of the mechanism of drug release. For a tablet having cylindrical shape, when n is below 0.45, the Fickian diffusion phenomenon dominates, and n between 0.45 and 0.89 is an anomalous transport (non-Fickian diffusion), often termed as first-order release. After the n value reaches 0.89 and above, the release can be characterized by case II and super case II transport, which means the drug release rate does not change over time and the release is characterized by zero order. In this case, the drug release is dominated by the erosion and swelling of the polymer. [11] [12] Mean dissolution time (MDT) was calculated from dissolution data according to Mockel and Lippold 7 using the following equation :
RESULTS AND DISCUSSION
To investigate the effects of polymer and their content level on drug release twelve formulations were prepared (Table 1 ). Formulation F-1, F-2 and F-3 fits with Korsmeyer kinetic model (R 2 =0.9767, R 2 =0.9781 and R 2 =0.9736 respectively) ( Table 2) .
The values of release exponent (n) for the above mentioned formulations are 0.7335, 0.7605 and 0.8337 respectively which indicates anomalous transport mechanism (coupling of the diffusion and erosion mechanism). 9 F-4 (R 2 =0.9667) has a value of release exponent (n) is 1.0074 which indicates case II and super case II transport, i.e. the drug release rate does not change over time and the release is characterized by zero order. In this case, the drug release is dominated by the erosion and swelling of the polymer.
10-11 Formulation F-5, F-6 and F-7 also The mean dissolution time (MDT) value is used to characterize the drug release rate from the dosage form and the retarding efficacy of the polymer. A higher value of MDT indicates a higher drug retarding ability of the polymer and vice versa. The MDT value was also found to be a function of polymer content and polymer nature. MDT values for all the twelve formulas are listed in Table 2 . From the table, it was observed that, MDT values were larger for those formulations which contained highest percentage of polymer.
Again, gastro retention time (GRT) is used to characterize the muco-adhesive strength of the dosage form inside the stomach. A higher value of GRT indicates a higher dosage form retaining ability on to the gut wall and vice versa. The GRT was also found to be dependent up on polymer content and polymer nature. The gastro retention time for all the twelve formulations are listed in Table 3 .
Effect of Methocel K4M on the release and bio-adhesive strength of Ciprofloxacin HCl loaded co-matrix tablets. Figure 1 (a) shows the effect of different concentration of Methocel K4M on drug release characteristics from Ciprofloxacin HCl. A significant difference in release pattern was observed among the formulations of F-1, F-2, F-3 and F-4. Ciprofloxacin HCl loaded F-1, F-2, F-3 and F-4 contain 50, 80, 110 and 140 mg of Methocel K4M Total Weight 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 . It is clearly evident that drug release was decreased with the increase in polymer loading. Methocel K4M is a class of hydrophilic matrix system which when comes in contact with liquid dissolution medium, forms fast and strong viscous gel to control initial drug release 12 . While HPMC could potentially retard the release of a soluble drug, it could also facilitate the release of relatively insoluble drug due to its solubilizing effect 12 . The hydrated gel matrix formed by HPMC is involved in the phenomenon of bio-adhesion. Bio- adhesive strength was determined using in-vitro wash-off method. Formulation F-1, F-2, F-3 and F-4 retained on the mucosa for 3.475, 3.810, 3.975 and 4.525 hours respectively. As the concentration of Methocel K4M increases and amount of Xanthan gum decreases, the bio-adhesive strength of corresponding formulation increases, possibly due to its more concentrated gel layer. 
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Effect of Methocel K15M CR on the release and bio-adhesive strength of Ciprofloxacin HCl loaded co-matrix tablets: Figure 1 (b) Effect of Methocel K100 LV on the release and bio-adhesive strength of Ciprofloxacin HCl loaded co-matrix tablets. The release profile of Ciprofloxacin HCl from Methocel K100 LV based co-matrix tablets is depicted in figure-1 (c) . This polymer exerted initial burst release within 1 hour irrespective of polymer content. Povidone K-30, being highly soluble in aqueous environment, is leached slowly from the matrix generating numerous pores and channels through which the drug is released by diffusion process. 13 Moreover, Ciprofloxacin HCl is highly water-soluble drug with pKa value 6.09 and 8.62 14 . Again Methocel K100LV CR has the lowest viscosity compared to Methocel K4M and Methocel K15M CR. All these effects contribute to the initial burst release. Retention capacity on gut wall was also less than those prepared with Methocel K4M and Methocel K15M CR.
